GB0026611D0 - Nucleoside derivatives - Google Patents

Nucleoside derivatives

Info

Publication number
GB0026611D0
GB0026611D0 GB0026611A GB0026611A GB0026611D0 GB 0026611 D0 GB0026611 D0 GB 0026611D0 GB 0026611 A GB0026611 A GB 0026611A GB 0026611 A GB0026611 A GB 0026611A GB 0026611 D0 GB0026611 D0 GB 0026611D0
Authority
GB
United Kingdom
Prior art keywords
nucleoside derivatives
nucleoside
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0026611A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Priority to GB0026611A priority Critical patent/GB0026611D0/en
Publication of GB0026611D0 publication Critical patent/GB0026611D0/en
Priority to US09/923,620 priority patent/US20030008841A1/en
Priority to KR10-2003-7003146A priority patent/KR20030061792A/en
Priority to PCT/EP2001/009633 priority patent/WO2002018404A2/en
Priority to CNA018164986A priority patent/CN1466591A/en
Priority to EP01976128A priority patent/EP1315736A2/en
Priority to CA002419399A priority patent/CA2419399A1/en
Priority to JP2002523918A priority patent/JP2004513083A/en
Priority to MXPA03001775A priority patent/MXPA03001775A/en
Priority to BR0113611-9A priority patent/BR0113611A/en
Priority to AU2001295497A priority patent/AU2001295497A1/en
Priority to PE2001000857A priority patent/PE20020410A1/en
Priority to ARP010104106A priority patent/AR030510A1/en
Priority to UY26914A priority patent/UY26914A1/en
Priority to PA20018528001A priority patent/PA8528001A1/en
Priority to US10/678,804 priority patent/US20040110718A1/en
Ceased legal-status Critical Current

Links

GB0026611A 2000-08-30 2000-10-31 Nucleoside derivatives Ceased GB0026611D0 (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
GB0026611A GB0026611D0 (en) 2000-10-31 2000-10-31 Nucleoside derivatives
US09/923,620 US20030008841A1 (en) 2000-08-30 2001-08-07 Anti-HCV nucleoside derivatives
AU2001295497A AU2001295497A1 (en) 2000-08-30 2001-08-21 Nucleoside derivatives for the treatment of Hepatitis C
CA002419399A CA2419399A1 (en) 2000-08-30 2001-08-21 Nucleoside derivatives for the treatment of hepatitis c
BR0113611-9A BR0113611A (en) 2000-08-30 2001-08-21 Nucleoside Derivatives
CNA018164986A CN1466591A (en) 2000-08-30 2001-08-21 Nucleoside derivatives
EP01976128A EP1315736A2 (en) 2000-08-30 2001-08-21 Nucleoside derivatives for the treatment of hepatitis c
KR10-2003-7003146A KR20030061792A (en) 2000-08-30 2001-08-21 Nucleoside derivatives
JP2002523918A JP2004513083A (en) 2000-08-30 2001-08-21 Nucleoside derivatives
MXPA03001775A MXPA03001775A (en) 2000-08-30 2001-08-21 Nucleoside derivatives.
PCT/EP2001/009633 WO2002018404A2 (en) 2000-08-30 2001-08-21 Nucleoside derivatives for the treatment of hepatitis c
PE2001000857A PE20020410A1 (en) 2000-08-30 2001-08-27 PURINE AND PYRIMIDINE NUCLEOSIDE DERIVATIVES AS INHIBITORS OF SUBGENOMIC HEPATITIS C VIRUS RNA REPLICATION
ARP010104106A AR030510A1 (en) 2000-08-30 2001-08-29 DERIVATIVES OF NUCLEOSIDS
UY26914A UY26914A1 (en) 2000-08-30 2001-08-29 NUCLEOSID DERIVATIVES
PA20018528001A PA8528001A1 (en) 2000-08-30 2001-08-30 NUCLEOSID DERIVATIVES
US10/678,804 US20040110718A1 (en) 2000-08-30 2003-10-03 Anti-HCV nucleoside derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0026611A GB0026611D0 (en) 2000-10-31 2000-10-31 Nucleoside derivatives

Publications (1)

Publication Number Publication Date
GB0026611D0 true GB0026611D0 (en) 2000-12-13

Family

ID=9902289

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0026611A Ceased GB0026611D0 (en) 2000-08-30 2000-10-31 Nucleoside derivatives

Country Status (1)

Country Link
GB (1) GB0026611D0 (en)

Similar Documents

Publication Publication Date Title
GC0000287A (en) Purine derivatives
GB0003960D0 (en) Purine derivatives
GB0022695D0 (en) Purine Derivatives
MXPA03001775A (en) Nucleoside derivatives.
HUP0301389A3 (en) Purine derivatives
HRP20030055A2 (en) 4-phenyl-pyridine derivatives
HK1054940A1 (en) Pyrimidine derivatives
IL150841A0 (en) 1h-imidazopyridine derivatives
AU1041802A (en) Tetrahydro-heterocycloazepinyl pyrimidine derivatives
HK1078079A1 (en) Pyrimidine derivatives
AU1397802A (en) Substituted c-cyclohexylmethylamine derivatives
AU8993701A (en) Substituted 1-aminobutan-3-ol derivatives
HK1052499A1 (en) Aminosulfonylbiphenyl derivatives
IL150558A0 (en) Aminomethyl-phenyl-cyclohexanone derivatives
AU2163202A (en) 5-amino-1-pentene-3-ol substituted derivatives
IL151598A0 (en) 2-phenylpyran-4-one derivatives
EP1295891A4 (en) Nucleoside derivatives
GB0026611D0 (en) Nucleoside derivatives
GB0021285D0 (en) Nucleoside derivatives
GB0014048D0 (en) Purine derivatives
GB0024920D0 (en) Purine derivatives
HK1054937A1 (en) 1-Methylcarbapenem derivatives
GB0021639D0 (en) Maurotoxin derivatives
SI1303496T1 (en) Pyrimidine derivatives

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)